Drug Database
Back to search

United States· US:33342-458_b6c5abdd-bc2d-4ed6-8ca2-8a94c406ed0e

Nebivolol

A nebivolol product containing nebivolol hydrochloride, registered in United States by Macleods Pharmaceuticals Limited. The same ATC class is registered in 16 of our 19 countries.

ATC C07AB12US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNebivololATCC07AB12REGISTER NO.US:33342-458_b6c5abdd…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nebivolol hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nebivolol is registered in 16 of 19 countries.

Countries holding a registration under ATC C07AB12 (nebivolol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search nebivolol products by name

Nebivolol · ATC C07AB12

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nebivolol costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.092 in United States to $0.39 in Switzerland — a ×4.2 gap.

  • United States: $0.092 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Nebivolol · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.39
  • ES Spain$0.32
  • IT Italy$0.25
  • FR France$0.14
  • US United States$0.092 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NEBIVOLOL HYDROCHLORIDE
Manufacturer
Macleods Pharmaceuticals Limited
Country
United States (US)
ATC code
C07AB12
ATC class
Nebivolol
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    33342-458-07
  • ndc11
    33342-458-10
  • ndc11
    33342-458-25
  • ndc11
    3334245807
    30 TABLET in 1 BOTTLE (33342-458-07)
  • ndc11
    3334245810
    90 TABLET in 1 BOTTLE (33342-458-10)
  • ndc11
    3334245825
    12 BLISTER PACK in 1 CARTON (33342-458-25) / 10 TABLET in 1 BLISTER PACK

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

273 interactions on record for nebivolol.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nebivolol against other medicinesHow interaction checks work

Nebivolol · interactions on record

273 records

  • 10 severe
  • 202 moderate
  • 17 minor

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe

44 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nebivolol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nebivolol products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Nebilan, Nebivolol +pharma
  • Belgium · Nebivolol Ab, Nebivolol Eg
  • Bulgaria · Nebilan, Nebivolol Sandoz
  • Cyprus · Lobivon, Nebivolol Accord
  • Czechia · Nebilet, Nebivolol Medreg
  • Germany · Nebilet, Nebivolol 089pharm
  • Denmark · Hypoloc, Nebivolol Accord
  • Estonia · Nebicard, Nebilet
  • Spain · Insucor, Lobivon
  • Finland · Hypoloc, Nebivolol Accord
  • France · Nebilox, Nebivolol Almus
  • United Kingdom (Northern Ireland) · Nebilet, Nebivolol
  • Greece · Bivol, Hypoloc
  • Croatia · Massido, Nebilet
  • Hungary · Nebibeta, Nebilet
  • Ireland · Nebilet, Nebimel
  • Italy · Lobivon, Nebilox
  • Lithuania · Nebicard, Nebilet
  • Luxembourg · Nebivolol Eg, Nobiten
  • Latvia · Nebilet, Nebivolol Actavis
  • Malta · Nebilet, Nebivolol Atb
  • Netherlands · Hypoloc, Lobivon
  • Poland · Daneb, Ebivol
  • Portugal · Nebilet, Nebivolol Aurovitas
  • Romania · Nebilet, Nebivolol Gemax Pharma
  • Slovenia · Nebilet, Nebivolol Krka
  • Slovakia · Nebilet, Nebitrix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed9d0a46-26cb-4a9f-83bf-07140952027d
GET /v1/drugs/ed9d0a46-26cb-4a9f-83bf-07140952027d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5",
  "substance": "NEBIVOLOL HYDROCHLORIDE",
  "productndc": "33342-458",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA212661",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about nebivolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console